Trial intelligence / Profile preview

Comparative study of Forteo vs Teribone in postmenopausal osteoporosis

jRCT1080225043Completed

Sponsor
Kamagaya General Hospital
Start
Jan 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Trial of teriparatide in osteoporosis (2 arms), sponsored by Kamagaya General Hospital. Started Jan 2020; status: completed.

02

Drugs

teriparatide
03

Conditions

osteoporosis

Beyond the preview

Go deeper on jRCT1080225043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080225043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call